Table 3 |
|
|
Current development status of NFκB pathway inhibitors. (Investigational Drugs DataBase, Nov 15 2005 [106], advanced search by activity field on Nuclear factor kappa B inhibitor) |
|
|
Development status |
No. of drugs |
|
|
|
|
Discovery Research |
22 |
|
Clinical (unspecified) |
1 |
|
Phase I clinical trials |
4 |
|
Phase II clinical trials |
4 |
|
Phase III clinical trials |
0 |
|
Pre-registered |
0 |
|
Registered |
0 |
|
Launched |
1 bortezomib |
|
Research tools |
1 |
|
Suspended |
0 |
|
Withdrawn |
0 |
|
No development reported |
4 |
|
Discontinued |
4 |
|
|
|
|
Hettne et al. Journal of Biomedical Discovery and Collaboration 2007 2:2 doi:10.1186/1747-5333-2-2 |
|
